Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
Annals of the Rheumatic DiseasesPublished 31 October 2014Open access
Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, C. Langenaken, V. Taelman
Citations124
SJR quartileQ1
SJR score5.73
SNIP4.44
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
For high-risk eRA, MTX associated with a moderate step-down dose of GCs was as effective in inducing remission at W16 as DMARD combination therapies with moderate or high step- down GC doses and it showed a more favourable short-term safety profile.
Abstract
2008-007225-39.
Keywords
Medicine
Annals of the Rheumatic DiseasesEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
5,775 Citations2017Josef S Smolen, Robert Landewé +47 more
These recommendations intend informing rheumatologists, patients, national rheumology societies, hospital officials, social security agencies and regulators about EULAR's most recent consensus on the management of RA, aimed at attaining best outcomes with current therapies.
Arthritis Care & Research2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
1,792 Citations2012Jasvinder A. Singh, Daniel E. Fürst +28 more
The 2012 ACR RA recommendations were developed by two expert panels: a non-voting working group and Core Expert Panel of clinicians and methodologists responsible for the selection of the relevant topic areas to be considered, the systematic literature review, and the evidence synthesis.
Annals of the Rheumatic DiseasesEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
1,762 Citations2013Josef S Smolen, Robert Landewé +31 more
The 2010 European League against Rheumatism recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological disease-modifying antirheumatic drugs (sDMARDs and b DMARDs, respectively) have been updated and are intended to improve outcome in patients with RA.
Arthritis & RheumatismClinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
1,459 Citations2005Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra +14 more
In patients with early RA, initial combination therapy including either prednisone or infliximab resulted in earlier functional improvement and less radiographic damage after 1 year than did sequential monotherapy or step-up combination therapy.
The LancetEffect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
1,403 Citations2004Catriona Grigor, Hilary A. Capell +6 more
A strategy of intensive outpatient management of rheumatoid arthritis substantially improves disease activity, radiographic disease progression, physical function, and quality of life at no additional cost.
The LancetRandomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
1,079 Citations1997Maarten Boers, Arco C. Verhoeven +13 more
This combined-therapy regimen offers additional disease control over and above that of sulphasalazine alone that persists for up to a year after corticosteroids are stopped.
The LancetComparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial
864 Citations1999Timo Möttönen, Pekka Hannonen +22 more
Combination therapy was better and not more hazardous than single treatment in induction of remission in early rheumatoid arthritis, and the combination strategy as an initial therapy seems to increase the efficacy of the treatment in at least a proportion of patients with early r HEA.
New England Journal of MedicineThe Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis
804 Citations1995John Kirwan
In patients with early, active rheumatoid arthritis, prednisolone given for two years in addition to other treatments substantially reduced the rate of radiologically detected progression of disease.
Arthritis & RheumatismCOBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention
615 Citations2002Robert Landewé, Maarten Boers +12 more
An initial 6-month cycle of intensive combination treatment that includes high-dose corticosteroids results in sustained suppression of the rate of radiologic progression in patients with early RA, independent of subsequent antirheumatic therapy.
New England Journal of MedicineCombination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
534 Citations1995Peter Tugwell, Theodore Pincus +8 more
In a six-month study, patients with severe rheumatoid arthritis and only partial responses to methotrexate had clinically important improvement after combination therapy with cyclosporine and metotrexate.
Annals of the Rheumatic DiseasesStandardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
534 Citations2002Frank Buttgereit, J A P Da Silva +9 more
PubMedComparison of treatment strategies in early rheumatoid arthritis: a randomized trial.
448 Citations2007Yvonne P M Goekoop-Ruiterman, Jeska K de Vries-Bouwstra +13 more
Arthritis & RheumatismA randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
388 Citations2012Larry W. Moreland, James R. O’Dell +11 more
Initial use of MTX monotherapy with the addition of sulfasalazine plus hydroxychloroquine (or etanercept, if necessary, after 6 months) is a reasonable therapeutic strategy for patients with early RA.
Arthritis & RheumatismGlucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action
363 Citations2004Frank Buttgereit, Rainer H. Straub +2 more
Recent insights relating to signaling, transcription processes, and gene expression as induced, inhibited, and/or modified by the interaction of GCs with their cytosolic receptors are reported, as well as relationships between dosages and plasma levels.
Cochrane Database of Systematic ReviewsEffects of glucocorticoids on radiological progression in rheumatoid arthritis
344 Citations2007John Kirwan, J. W. J. Bijlsma +2 more
Even in the most conservative estimate, the evidence that glucocorticoids given in addition to standard therapy can substantially reduce the rate of erosion progression in rheumatoid arthritis is convincing.
Arthritis & RheumatismTreatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two‐year, randomized, double‐blind, placebo‐controlled trial
322 Citations2002James R. O’Dell, Robert D. Leff +15 more
The triple combination of MTX, SSZ, and HCQ is well-tolerated, and its efficacy is superior to that of the double combination ofMTX and SSZ and is marginally superior toThat of thedouble combination ofmtX andHCQ.
The LancetAddition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
316 Citations2009Ronald van Vollenhoven, Sofia Ernestam +17 more
In patients with early rheumatoid arthritis in whom methotrexate treatment failed, addition of a tumour necrosis factor antagonist to methot Rexate monotherapy is clinically superior to addition of conventional disease-modifying antirheumatic drugs.
Annals of Internal MedicineLow-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
314 Citations2012Marije F. Bakker, Johannes W.G. Jacobs +13 more
Adding low-dose prednisone at the start of a methotrexate-based treatment strategy for tight control in early rheumatoid arthritis increases its effectiveness and improves patient outcomes.
Arthritis & RheumatismRetardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: Five‐year experience from the FIN‐RACo study
277 Citations2004Markku Korpela, Leena Laasonen +8 more
The results confirm the earlier concept that triple therapy with combinations of DMARDs contributes to an improved long-term radiologic outcome in patients with early and clinically active RA.
Arthritis & RheumatismDisease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients
266 Citations2007Daniel Aletaha, Julia Funovits +2 more
The findings indicate that intensive and dynamic treatment strategies that include a closer look at disease activity at 3 months in patients with early and late RA is warranted, and patients who reach a moderate or low disease activity status after 3-6 months of therapy may require switching to alternative therapies.
Annals of the Rheumatic DiseasesCombination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
263 Citations1999M. Dougados, B. Combe +10 more
This study suggests that an early initiation therapy of disease modifying drug seems to be of benefit, however, this study was unable to demonstrate a clinically relevant superiority of the combination therapy although several outcomes were in favour of this observation.
Arthritis & RheumatismClinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
196 Citations2008Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra +14 more
In patients with early RA, initial combination therapy including either prednisone or infliximab resulted in earlier functional improvement and less radiographic damage after 1 year than did sequential monotherapy or step-up combination therapy.
Annals of the Rheumatic DiseasesCurrent evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
183 Citations2010Simone Gorter, J. W. J. Bijlsma +5 more
Annals of the Rheumatic DiseasesPerformance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
170 Citations2013Helga Radner, Tuhina Neogi +2 more
The 2010 ACR/EULAR classification criteria for rheumatoid arthritis are sensitive to detect cases of RA among various target populations, independent of how the latter is referenced.
Nature Reviews RheumatologyCurrent view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis
152 Citations2010Jos N. Hoes, Johannes W. G. Jacobs +2 more
Studies of the rationale for and clinical use of glucocorticoids as co-therapy with DMARDs in RA have shown that this approach has a place in modern (tight control) treatment strategies, and that glucocortsicoid co-Therapy has disease-modifying effects during the first 2 years of treatment in patients with early RA.
Arthritis & RheumatismSimilar effects of disease‐modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta‐analysis of 70 randomized placebo‐controlled or drug‐controlled studies, including 112 comparisons
136 Citations2010Niels Graudal, Gesche Jűrgens
Treatment with DMARDs, glucocorticoids, biologic agents, and combination agents significantly reduced radiographic progression at 1 year, with a relative effect of 48-84%.
Annals of the Rheumatic DiseasesInduction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
136 Citations2012P.H. de Jong, Johanna M. W. Hazes +10 more
Triple DMARD induction therapy is better than MTX monotherapy in early RA and no differences were seen in medication adjustments due to adverse events after stratification for drug.
Annals of the Rheumatic DiseasesDAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
135 Citations2009Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra +9 more
In patients with recent-onset rheumatoid arthritis receiving traditional treatment, systematic DAS-driven therapy results in significantly better clinical improvement and possibly improves the suppression of joint damage progression.
BMJManagement of rheumatoid arthritis: summary of NICE guidance
135 Citations2009Chris Deighton, Rachel O’Mahony +4 more
The recommendations in the guideline from the National Institute for Health and Clinical Excellence (NICE) on the management of rheumatoid arthritis, from early identification to managing chronic and severe disease are summarized.
PubMedCombination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.
133 Citations2000Meral Çalgünerı, S. Pay +5 more
It is suggested that patients with RA should be treated with combinations of DMARDs, as the combination of MTX + SSZ + HCQ was more effective than both monotherapy and the two-drug combinations.
PubMedSustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
126 Citations2007Heidi Mäkinen, Hannu Kautiainen +8 more
A remarkable proportion of patients with early RA treated with combinations of DMARD were in remission at 2 years, and remission was more often sustained compared to patients treated with a single DMARD.
Annals of the Rheumatic DiseasesAdalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
124 Citations2013Kim Hørslev‐Petersen, Merete Lund Hetland +27 more
Adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment did not increase the proportion of patients who reached the DAS28CRP<3.2 treatment target, but improved DAS 28CRP, remission rates, function and quality of life in DMARD-naïve ERA.
Annals of the Rheumatic DiseasesSurvival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis
121 Citations2009L. van Tuyl, M. Boers +14 more
After 11 years, initial COBRA combination therapy resulted in numerically lower mortality and similar prevalence of comorbidity compared with initial SSZ monotherapy, and lower progression of joint damage suggests long-term disease modification.
Archives of Internal MedicineReduced Loss of Hand Bone Density With Prednisolone in Early Rheumatoid Arthritis
117 Citations2005Glenn Haugeberg, Anders Strand +2 more
This is the first double-blind randomized study to show that disease-related loss of hand bone density in rheumatoid arthritis can be decelerated by prednisolone, suggesting that the deleterious effect of prednisOLone on bone may be counteracted by its anti-inflammatory effect.
Annals of the Rheumatic DiseasesA non-inferiority trial of an attenuated combination strategy (‘COBRA-light‘) compared to the original COBRA strategy: clinical results after 26 weeks
100 Citations2013Debby den Uyl, Marieke M. ter Wee +9 more
COBRA-light therapy is most likely non-inferior to COBRA therapy at 6 months, and minimal disease activity (DAS44 <1.6) was reached in almost half of patients in both groups.
Annals of the Rheumatic DiseasesInfliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)
96 Citations2012Marjatta Leirisalo‐Repo, Hannu Kautiainen +31 more
Most patients with early active RA achieve clinical remission and develop negligible joint damage with the intensified FIN-RACo regimen, and adding INFL for the first 6 months delays radiological progression.
Best Practice & Research Clinical RheumatologyGlucocorticoids
90 Citations2011Cornelia M. Spies, Cindy Strehl +3 more
Improved knowledge of the immunomodulatory role of endogenous glucocorticoids has evolved, and the therapeutic potential of targeting glucocorticoid pre-receptor metabolism for metabolic and inflammatory diseases is reported.
Arthritis & RheumatismValidation of the Methotrexate‐First Strategy in Patients With Early, Poor‐Prognosis Rheumatoid Arthritis: Results From a Two‐Year Randomized, Double‐Blind Trial
83 Citations2013James R. O’Dell, Jeffrey R. Curtis +6 more
These results in patients with early, poor prognosis RA validate the strategy of starting with MTX monotherapy, and are the first to demonstrate in a blinded trial that initial MTx monotherapy with the option to step-up to combination therapy results in similar outcomes to immediate combination therapy.
Cochrane Database of Systematic ReviewsMethotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis
82 Citations2010Wanruchada Katchamart, Judith Trudeau +2 more
A moderate level of evidence from the systematic review showed no statistically significant advantage of the MTX combination versus monotherapy, and trials are needed that compare currently used MTX doses and combination therapies.
Lara D. VeekenDaily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis
76 Citations2007Patrick Verschueren, Greet Esselens +1 more
In daily practice, a step-down treatment strategy for early RA is more effective than astep-up approach, and methotrexate proved to be the most effective maintenance therapy after step- down.
Lara D. VeekenA systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis
75 Citations2009H. Y. Margaret, Gabrielle Kingsley +1 more
There is strong evidence in favour of combination treatment for RA but there is still uncertainty about which regimen is preferable, and both combination DMARDs and TNF/MTX are more effective than MTX monotherapy.
PubMedCCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
59 Citations2012Francesca Bandinelli, Angela Del Rosso +5 more
The high levels of circulating chemokines might support a role of MCP1/CCL2, RANTES/ CCL5 and MIP1α/CCl3 in SSc pathogenesis and the correlation of M CP-1 with the extent of skin fibrosis might imply its involvement in the development of fibrosis in S Sc.
Lara D. VeekenDiscordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis
56 Citations2008L. van Tuyl, Anne Marie Plass +5 more
Rheumatologists were particularly concerned about their patients' reaction towards them prescribing such an aggressive and complex therapy, whereas patients, while aware of the side-effects, were most interested in suppressing illness symptoms and reducing future damage regardless of the amount of pills.
Scandinavian Journal of RheumatologyPredictors of remission, normalized physical function, and changes in the working situation during follow‐up of patients with early rheumatoid arthritis: an observational study
49 Citations2009Patrick Verschueren, Greet Esselens +1 more
It is found that month 4 disease response predicts later remission, normalized physical function, and work change in RA.
The Journal of RheumatologyFive-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort
48 Citations2013Bernard Combe, Nathalie Rincheval +18 more
The generally good 5-year outcome of an early RA cohort in the 2000s could be related to early referral and early effective treatment, key processes in the management of early RA in daily practice.
Annals of the Rheumatic DiseasesWhy are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
39 Citations2007L. van Tuyl, Anne Marie Plass +4 more
The reluctance of Dutch rheumatologists to prescribe effective COBRA therapy may be due to perceptions of complexity of the treatment schedule and negative patient-related consequences of the therapy.
Musculoskeletal CareEffectiveness of an integrated outpatient care programme compared with present‐day standard care in early rheumatoid arthritis
36 Citations2008Greet Esselens, René Westhovens +1 more
Disease activity was better controlled and functionality and general health better preserved in patients following an outpatient care programme, partly due to the easier implementation of an intensive initial treatment strategy but apparently also to other aspects of organized pharmacological and non-pharmacological care.
Lara D. VeekenOptimal care for early RA patients: the challenge of translating scientific data into clinical practice
24 Citations2011Patrick Verschueren, R. Westhovens
There does not seem to have been a difference in terms of efficacy between intensive RA treatment strategies based on a combination of classical DMARDs with glucocorticoids or with TNF-blocking agents, but given the costs biologicals cannot be considered first-line therapy.
PubMedThe CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis.
24 Citations2013Merete Lund Hetland, Kim Hørslev‐Petersen
MTX and i.a.GC in a treat-to-target strategy over 5 years halted radiographic progression and induced remission in the majority of patients and had in long-lasting effect and cumulated dosages were low.
Scandinavian Journal of RheumatologyFactors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis
19 Citations2014Sabrina Meyfroidt, Laura van Hulst +6 more
A heterogeneous set of factors highlights the complexity of prescribing ICTS for early RA in daily clinical practice as well as identifying the facilitators and addressing the barriers.
Clinical RheumatologyTwo-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice
19 Citations2013Danny De Cock, Geert Vanderschueren +4 more
ICTS seems to be more effective than IMT in achieving higher remission rates and less radiographic progression, in a TC setting, over 2 years of patients with early rheumatoid arthritis.
Annals of the Rheumatic DiseasesFRI0296 Is There A Difference in the Effectiveness in the Treatment of Rheumatoid Arthritis with Rituximab in Patients with Rheumatoid Factor Positive and Negative? A Systematic Review
18 Citations2014A.M. Ortiz, María Piedad Rosario Lozano +2 more
RTX shows greater efficacy in the treatment of RA patients seropositive respect to seronegative, both in intensity and response rate (level of evidence 1a, grade of recommendation A).